Cancer or Tumor Profiling Market Size, Share, Trends, Industry Analysis Report: By Cancer Type, Technology, Technique, Application, and Region

Description

List of Tables

The global cancer or tumor profiling market size is expected to reach USD 35.36 billion by 2034, according to a new study by Polaris Market Research. The report "Cancer or Tumor Profiling Market Size, Share, Trends, Industry Analysis Report: By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, and Others), Technology, Technique, Application, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The cancer or tumor profiling market expansion is driven by the increasing prevalence of cancer worldwide and the growing demand for personalized medicine. Key drivers include advancements in genomic technologies such as next-generation sequencing (NGS) and liquid biopsy, which enable early detection, better diagnosis, and more targeted treatments. Cancer or tumor profiling market opportunities exist in emerging markets, where rising healthcare access and awareness are boosting the adoption of cancer profiling technologies.

Trends such as the integration of artificial intelligence (AI) for data analysis and the growing focus on noninvasive diagnostic techniques are shaping the market. With ongoing innovations in biomarker discovery and regulatory support for precision diagnostics, the market is poised for continued expansion, with a heightened emphasis on improving patient outcomes through personalized and more effective treatment strategies.

Cancer or Tumor Profiling Market Report Highlights

The breast cancer segment, by cancer type, holds the largest cancer or tumor profiling market share due to its high prevalence and the growing demand for personalized treatments and genomic profiling. However, the lung cancer segment is registering the highest growth due to the increasing use of liquid biopsy and advanced genomic profiling for early detection and targeted therapies.

By technology, the next-generation sequencing (NGS) segment dominates the market, offering comprehensive insights into tumor genetic profiles and driving precision oncology. The polymerase chain reaction (PCR) segment is the fastest-growing technology segment, fueled by its cost-effectiveness and application in liquid biopsy for early cancer detection.

The genomics segment, based on technique, leads the cancer or tumor profiling market revenue share due to its ability to provide in-depth molecular data on mutations, gene expressions, and tumor heterogeneity, which are critical for personalized medicine. The epigenetics segment is experiencing the highest growth, driven by its role in uncovering molecular mechanisms that drive cancer progression and response to treatment.

In terms of application, the personalized medicine segment dominates the market, as more oncologists adopt genomic and biomarker-based testing to guide treatment decisions and improve patient outcomes. The biomarker discovery segment is growing rapidly as new and more precise biomarkers are being identified for early detection and monitoring of cancer progression.

North America holds the largest market share, supported by its advanced healthcare infrastructure and strong focus on precision oncology. Asia Pacific is the fastest-growing market, driven by increasing healthcare access, rising cancer rates, and expanding adoption of cancer profiling technologies.

Polaris Market Research has segmented the cancer or tumor profiling market report on the basis of cancer type, technology, technique, application, and region:

By Cancer Type Outlook (Revenue - USD Billion, 2020-2034)

Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Melanoma Cancer
Others

By Technology Outlook (Revenue - USD Billion, 2020-2034)

Next-Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
In-Situ Hybridization (ISH)
Microarray
Others

By Technique Outlook (Revenue - USD Billion, 2020-2034)

Genomics
Proteomics
Epigenetics
Metabolomics

By Application Outlook (Revenue - USD Billion, 2020-2034)

Personalized Medicine
Diagnostics
Biomarker Discovery
Prognostics
Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

Product Code: PM1713

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Cancer or Tumour Profiling Market Insights

4.1. Global Cancer or Tumour Profiling Market - Market Snapshot
4.2. Global Cancer or Tumour Profiling Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Integration of Liquid Biopsy in Diagnostics
  - 4.2.1.2. Growing Role of Next-Generation Sequencing (NGS)
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High Cost of Profiling Technologies
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Global Cancer or Tumour Profiling Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Cancer or Tumour Profiling Market, by Cancer Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
5.3. Breast Cancer
- 5.3.1. Global Cancer or Tumour Profiling Market, by Breast Cancer, by Region, 2020-2034 (USD Billion)
5.4. Lung Cancer
- 5.4.1. Global Cancer or Tumour Profiling Market, by Lung Cancer, by Region, 2020-2034 (USD Billion)
5.5. Colorectal Cancer
- 5.5.1. Global Cancer or Tumour Profiling Market, by Colorectal Cancer, by Region, 2020-2034 (USD Billion)
5.6. Prostate Cancer
- 5.6.1. Global Cancer or Tumour Profiling Market, by Prostate Cancer, by Region, 2020-2034 (USD Billion)
5.7. Melanoma Cancer
- 5.7.1. Global Cancer or Tumour Profiling Market, by Melanoma Cancer, by Region, 2020-2034 (USD Billion)
5.8. Others
- 5.8.1. Global Cancer or Tumour Profiling Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Cancer or Tumour Profiling Market, by Technology

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
6.3. Next-Generation Sequencing (NGS)
- 6.3.1. Global Cancer or Tumour Profiling Market, by Next-Generation Sequencing (NGS), by Region, 2020-2034 (USD Billion)
6.4. Polymerase Chain Reaction (PCR)
- 6.4.1. Global Cancer or Tumour Profiling Market, by Bakery & Confectionary, by Region, 2020-2034 (USD Billion)
6.5. Immunohistochemistry (IHC)
- 6.5.1. Global Cancer or Tumour Profiling Market, by Immunohistochemistry (IHC), by Region, 2020-2034 (USD Billion)
6.6. In-Situ Hybridization (ISH)
- 6.6.1. Global Cancer or Tumour Profiling Market, by In-Situ Hybridization (ISH), by Region, 2020-2034 (USD Billion)
6.7. Microarray
- 6.7.1. Global Cancer or Tumour Profiling Market, by Microarray, by Region, 2020-2034 (USD Billion)
6.8. Others
- 6.8.1. Global Cancer or Tumour Profiling Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Cancer or Tumour Profiling Market, by Technique

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
7.3. Genomics
- 7.3.1. Global Cancer or Tumour Profiling Market, by Genomics, by Region, 2020-2034 (USD Billion)
7.4. Proteomics
- 7.4.1. Global Cancer or Tumour Profiling Market, by Proteomics, by Region, 2020-2034 (USD Billion)
7.5. Epigenetics
- 7.5.1. Global Cancer or Tumour Profiling Market, by Epigenetics, by Region, 2020-2034 (USD Billion)
7.6. Metabolomics
- 7.6.1. Global Cancer or Tumour Profiling Market, by Metabolomics, by Region, 2020-2034 (USD Billion)

8. Global Cancer or Tumour Profiling Market, by Application

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
8.3. Personalized Medicine
- 8.3.1. Global Cancer or Tumour Profiling Market, by Personalized Medicine, by Region, 2020-2034 (USD Billion)
8.4. Diagnostics
- 8.4.1. Global Cancer or Tumour Profiling Market, by Diagnostics, by Region, 2020-2034 (USD Billion)
8.5. Biomarker Discovery
- 8.5.1. Global Cancer or Tumour Profiling Market, by Biomarker Discovery, by Region, 2020-2034 (USD Billion)
8.6. Prognostics
- 8.6.1. Global Cancer or Tumour Profiling Market, by Prognostics, by Region, 2020-2034 (USD Billion)
8.7. Others
- 8.7.1. Global Cancer or Tumour Profiling Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global Cancer or Tumour Profiling Market, by Geography

9.1. Key Findings
9.2. Introduction
- 9.2.1. Global Cancer or Tumour Profiling Market Assessment, By Geography, 2020-2034 (USD billion)
9.3. Global Cancer or Tumour Profiling Market - North America
- 9.3.1. North America: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
- 9.3.2. North America: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
- 9.3.3. North America: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
- 9.3.4. North America: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.3.5. Global Cancer or Tumour Profiling Market - US
  - 9.3.5.1. US: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.3.5.2. US: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.3.5.3. US: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.3.5.4. US: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.3.6. Global Cancer or Tumour Profiling Market - Canada
  - 9.3.6.1. Canada: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.3.6.2. Canada: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.3.6.3. Canada: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.3.6.4. Canada: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
9.4. Global Cancer or Tumour Profiling Market - Europe
- 9.4.1. Europe: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
- 9.4.2. Europe: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
- 9.4.3. Europe: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
- 9.4.4. Europe: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.4.5. Global Cancer or Tumour Profiling Market - UK
  - 9.4.5.1. UK: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.4.5.2. UK: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.4.5.3. UK: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.4.5.4. UK: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.4.6. Global Cancer or Tumour Profiling Market - France
  - 9.4.6.1. France: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.4.6.2. France: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.4.6.3. France: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.4.6.4. France: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.4.7. Global Cancer or Tumour Profiling Market - Germany
  - 9.4.7.1. Germany: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.4.7.2. Germany: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.4.7.3. Germany: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.4.7.4. Germany: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.4.8. Global Cancer or Tumour Profiling Market - Italy
  - 9.4.8.1. Italy: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.4.8.2. Italy: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.4.8.3. Italy: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.4.8.4. Italy: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.4.9. Global Cancer or Tumour Profiling Market - Spain
  - 9.4.9.1. Spain: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.4.9.2. Spain: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.4.9.3. Spain: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.4.9.4. Spain: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.4.10. Global Cancer or Tumour Profiling Market - Netherlands
  - 9.4.10.1. Netherlands: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.4.10.2. Netherlands: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.4.10.3. Netherlands: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.4.10.4. Netherlands: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.4.11. Global Cancer or Tumour Profiling Market - Russia
  - 9.4.11.1. Russia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.4.11.2. Russia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.4.11.3. Russia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.4.11.4. Russia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.4.12. Global Cancer or Tumour Profiling Market - Rest of Europe
  - 9.4.12.1. Rest of Europe: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.4.12.2. Rest of Europe: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.4.12.3. Rest of Europe: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.4.12.4. Rest of Europe: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
9.5. Global Cancer or Tumour Profiling Market - Asia Pacific
- 9.5.1. Asia Pacific: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
- 9.5.2. Asia Pacific: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
- 9.5.3. Asia Pacific: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
- 9.5.4. Asia Pacific: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.5.5. Global Cancer or Tumour Profiling Market - China
  - 9.5.5.1. China: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.5.5.2. China: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.5.5.3. China: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.5.5.4. China: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.5.6. Global Cancer or Tumour Profiling Market - India
  - 9.5.6.1. India: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.5.6.2. India: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.5.6.3. India: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.5.6.4. India: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.5.7. Global Cancer or Tumour Profiling Market - Malaysia
  - 9.5.7.1. Malaysia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.5.7.2. Malaysia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.5.7.3. Malaysia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.5.7.4. Malaysia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.5.8. Global Cancer or Tumour Profiling Market - Japan
  - 9.5.8.1. Japan: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.5.8.2. Japan: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.5.8.3. Japan: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.5.8.4. Japan: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.5.9. Global Cancer or Tumour Profiling Market - Indonesia
  - 9.5.9.1. Indonesia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.5.9.2. Indonesia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.5.9.3. Indonesia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.5.9.4. Indonesia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.5.10. Global Cancer or Tumour Profiling Market - South Korea
  - 9.5.10.1. South Korea: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.5.10.2. South Korea: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.5.10.3. South Korea: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.5.10.4. South Korea: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.5.11. Global Cancer or Tumour Profiling Market - Australia
  - 9.5.11.1. Australia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.5.11.2. Australia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.5.11.3. Australia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.5.11.4. Australia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.5.12. Global Cancer or Tumour Profiling Market - Rest of Asia Pacific
  - 9.5.12.1. Rest of Asia Pacific: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.5.12.2. Rest of Asia Pacific: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.5.12.3. Rest of Asia Pacific: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.5.12.4. Rest of Asia Pacific: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
9.6. Global Cancer or Tumour Profiling Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
- 9.6.2. Middle East & Africa: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
- 9.6.3. Middle East & Africa: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
- 9.6.4. Middle East & Africa: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.6.5. Global Cancer or Tumour Profiling Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.6.5.2. Saudi Arabia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.6.5.3. Saudi Arabia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.6.5.4. Saudi Arabia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.6.6. Global Cancer or Tumour Profiling Market - UAE
  - 9.6.6.1. UAE: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.6.6.2. UAE: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.6.6.3. UAE: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.6.6.4. UAE: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.6.7. Global Cancer or Tumour Profiling Market - Israel
  - 9.6.7.1. Israel: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.6.7.2. Israel: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.6.7.3. Israel: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.6.7.4. Israel: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.6.8. Global Cancer or Tumour Profiling Market - South Africa
  - 9.6.8.1. South Africa: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.6.8.2. South Africa: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.6.8.3. South Africa: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.6.8.4. South Africa: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.6.9. Global Cancer or Tumour Profiling Market - Rest of Middle East & Africa
  - 9.6.9.1. Rest of Middle East & Africa: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.6.9.2. Rest of Middle East & Africa: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.6.9.3. Rest of Middle East & Africa: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.6.9.4. Rest of Middle East & Africa: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
9.7. Global Cancer or Tumour Profiling Market - Latin America
- 9.7.1. Latin America: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
- 9.7.2. Latin America: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
- 9.7.3. Latin America: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
- 9.7.4. Latin America: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.7.5. Global Cancer or Tumour Profiling Market - Mexico
  - 9.7.5.1. Mexico: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.7.5.2. Mexico: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.7.5.3. Mexico: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.7.5.4. Mexico: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.7.6. Global Cancer or Tumour Profiling Market - Brazil
  - 9.7.6.1. Brazil: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.7.6.2. Brazil: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.7.6.3. Brazil: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.7.6.4. Brazil: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.7.7. Global Cancer or Tumour Profiling Market - Argentina
  - 9.7.7.1. Argentina: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.7.7.2. Argentina: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.7.7.3. Argentina: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.7.7.4. Argentina: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
- 9.7.8. Global Cancer or Tumour Profiling Market - Rest of Latin America
  - 9.7.8.1. Rest of Latin America: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  - 9.7.8.2. Rest of Latin America: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  - 9.7.8.3. Rest of Latin America: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  - 9.7.8.4. Rest of Latin America: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. Illumina
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. Thermo Fisher Scientific
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. Qiagen
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. F. Hoffmann-La Roche
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. Agilent Technologies
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. Bio-Rad Laboratories
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. PerkinElmer
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. Foundation Medicine (a Roche subsidiary)
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. Guardant Health
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. NeoGenomics Laboratories
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
11.11. Pacific Biosciences
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
11.12. Personalis
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
11.13. GRAIL (a subsidiary of Illumina)
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
11.14. Invitae
- 11.14.1. Company Overview
- 11.14.2. Financial Performance
- 11.14.3. Product Benchmarking
- 11.14.4. Recent Development
11.15. Genomic Health (a subsidiary of Exact Sciences)
- 11.15.1. Company Overview
- 11.15.2. Financial Performance
- 11.15.3. Product Benchmarking
- 11.15.4. Recent Development